Meet us at Emergency Conference SWEET on March 13-15 in Stockholm, Sweden and hear about suPARnostic®

New abstract published in Immunity & Ageing;
"Healthy lifestyles reduce suPAR and mortality in a Danish general population study" by Haupt T.H. et al.

New abstract published in World Journal of Surgery;
"Soluble Urokinase Plasminogen Activator Receptor (suPAR) as an Added Predictor to Existing Preoperative Risk Assessments" by Alstrup M et al.

ViroGates is expanding and has welcomed 5 new employees since November 1, 2018.

The ViroGates team now includes 4 new members responsible for Sales and Business Development in Scandinavia, Germany, France and Spain, as well as an International Application Scientist.